Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.18632/oncotarget.17303 http://scihub22266oqcxt.onion/10.18632/oncotarget.17303 C5601166!5601166!28947998     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Oncotarget 2017 ; 8 (36): 60605-23 Nephropedia Template TP {{tp|p=28947998|t=2017. Long non-coding RNAs in B-cell malignancies: a comprehensive overview |pdf=|usr=}}{{28947998}} gab.com Text Long non-coding RNAs in B-cell malignancies: a comprehensive overview JO: Oncotarget http://www.kidney.de/pget.php?&tw=1&pmid=28947998 #FOAvip B-cell malignancies constitute a large part of hematological neoplasias. They represent a heterogeneous group of diseases, including Hodgkin's lymphoma, most non-Hodgkin's lymphomas (NHL), some leukemias and myelomas. B-cell malignancies reflect defined stages of normal B-cell differentiation and this represents the major basis for their classification. Long non-coding RNAs (lncRNAs) are non-protein-coding transcripts longer than 200 nucleotides, for which many recent studies have demonstrated a function in regulating gene expression, cell biology and carcinogenesis. Deregulated expression levels of lncRNAs have been observed in various types of cancers including hematological malignancies. The involvement of lncRNAs in cancer initiation and progression and their attractive features both as biomarker and for therapeutic research are becoming increasingly evident. In this review, we summarize the recent literature to highlight the status of the knowledge of lncRNAs role in normal B-cell development and in the pathogenesis of B-cell tumors. Twit Text FOAVip Long non-coding RNAs in B-cell malignancies: a comprehensive overview ????Oncotarget http://www.kidney.de/pget.php?&tw=1&pmid=28947998 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28947998 #FOAvip English Wikipedia <ref>{{Cite pmid|28947998}}</ref> Long non-coding RNAs in B-cell malignancies: a comprehensive overview #MMPMID28947998 Nobili L; Ronchetti D; Taiana E; Neri A Oncotarget 2017[Sep]; 8 (36): 60605-23 PMID28947998show ga B-cell malignancies constitute a large part of hematological neoplasias. They represent a heterogeneous group of diseases, including Hodgkin's lymphoma, most non-Hodgkin's lymphomas (NHL), some leukemias and myelomas. B-cell malignancies reflect defined stages of normal B-cell differentiation and this represents the major basis for their classification. Long non-coding RNAs (lncRNAs) are non-protein-coding transcripts longer than 200 nucleotides, for which many recent studies have demonstrated a function in regulating gene expression, cell biology and carcinogenesis. Deregulated expression levels of lncRNAs have been observed in various types of cancers including hematological malignancies. The involvement of lncRNAs in cancer initiation and progression and their attractive features both as biomarker and for therapeutic research are becoming increasingly evident. In this review, we summarize the recent literature to highlight the status of the knowledge of lncRNAs role in normal B-cell development and in the pathogenesis of B-cell tumors. äLong non-coding RNAs in B-cell malignancies: a comprehensive overview (epmc).pdf DeepDyve Pubget Overpricing